Exelixis

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
954
Employees954
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
954
Employees954

EXEL Key Statistics

Market cap
5.27B
Market cap5.27B
Price-Earnings ratio
17.56
Price-Earnings ratio17.56
Dividend yield
Dividend yield
Average volume
1.55M
Average volume1.55M
High today
$16.75
High today$16.75
Low today
$16.16
Low today$16.16
Open price
$16.66
Open price$16.66
Volume
1.85M
Volume1.85M
52 Week high
$23.40
52 Week high$23.40
52 Week low
$14.87
52 Week low$14.87

EXEL News

Yahoo Finance 7d
Why Is Exelixis Up 0.4% Since Last Earnings Report? - Yahoo Finance

It has been about a month since the last earnings report for Exelixis (EXEL). Shares have added about 0.4% in that time frame, underperforming the S&P 500. Wil...

Why Is Exelixis Up 0.4% Since Last Earnings Report? - Yahoo Finance

Analyst ratings

81%

of 16 ratings
Buy
81.3%
Hold
12.5%
Sell
6.3%

EXEL Earnings

$0.00
$0.12
$0.25
$0.37
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 16, After Hours
ActualExpected Feb 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.